Searchable abstracts of presentations at key conferences in obesity

ob0002p8 | (1) | OU2020

Proglucagon peptide secretion post Roux-en-Y gastric bypass: one year prospective study

Alexiadou Kleopatra , Cuenco Joyceline , Howard James , Albrechtsen Nicolai Wewer , Ilesanmi Ibeyimi , Kamocka Anna , Tharakan George , Behary Preeshila , Ahmed Ahmed R , Holst Jens J , Bloom Stephen R , Khoo Bernard , Tan Tricia M

Background: Hyperglucagonaemia is one of the key players in the pathophysiology of type 2 diabetes. Roux-en-Y Gastric Bypass (RYGB) is currently a highly effective treatment for weight loss and diabetes remission. However, the role of glucagon in the above effects is unclear.Aim: To characterise the behaviour of proglucagon-derived peptides (glucagon, glucagon-like peptide-1, oxyntomodulin, glicentin) after RYGB surgery.Subjects an...